Company Search:
Advanced Search
Sponsored Links
Medincell SA Company Snapshot
Medincell SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medincell SA with three other pharmaceutical manufacturers in Europe: Oncimmune Holdings PLC of the United Kingdom (2019 sales of £171,000.00 [US$221,215.86 ] of which 100% was Distribution of testing products), Diurnal Group PLC of the United Kingdom (£1.04 million [US$1.35 million] of which 100% was Alkindi), and Oasmia Pharmaceutical AB which is based in Sweden (1.98 million Swedish Kronor [US$207,504.00 ] of which 65% was Sales of goods).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medincell SA
  Stock Performance Chart for Medincell SA
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 7.34
(Figures in Euro)
1 Week 9.2%   13 Weeks 3.7%  
4 Weeks 6.4%   52 Weeks 4.1%  
Medincell SA Key Data:
  Ticker: MEDCL Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 1,442,000
(Year Ending Jan 2020).
Employees: 124
  Currency: Euro Market Cap: 147,334,007
  Fiscal Yr Ends: March Shares Outstanding: 20,072,753
  Share Type: ACTIONS ORDINAIRES Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.